Skip to content

Author

V. Cherubini

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

SIRENA protocol: an Italian, prospective, multicentre cohort study of children and adults with islet autoimmunity and early-stage type 1 diabetes

Abstract Introduction Type 1 diabetes (T1D) is a progressive autoimmune disease with identifiable presymptomatic stages. Islet autoantibody screening, expanded in Italy by Law 130/2023, identifies children and adults at high risk of progression. Structured longitudinal follow-up is needed to characterise disease trajec...

V. Cherubini, R. Gesuita, E. Mozzillo et al. · 0 citations
Open access Aug 2026

Increasing incidence and clinical burden of paediatric type 1 diabetes in Italy: insights from a large administrative database.

BACKGROUND Paediatric type 1 diabetes (T1D) is a chronic disease that represents a global public health concern. Italian data describing epidemiology, comorbidity burden, and healthcare resource utilisation (HCRU) of paediatric T1D remain fragmented, mostly deriving from regional registries or limited cohorts. METHOD...

E. Mozzillo, C. Trimarchi, R. Buzzetti et al. · 0 citations
Review Open access Sep 2026

Diagnosis and management of bone fragility fractures in children and adolescents: Good Clinical Practice Recommendations of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED)

These recommendations, revised and approved by the Italian National Institute of Health, aim to provide clinicians with a structured and evidence-based approach to improve the early identification, diagnostic work-up, and management of pediatric patients with bone fragility, promoting standardized care and reducing var...

L. de Sanctis, G. Baroncelli, B. Pintaudi et al. · 0 citations
Aug 2026

Continuous Glucose Monitoring and Automated Insulin Delivery in Infants with Type 1 Diabetes: Real-World Evidence to Support Future International Guidelines.

CGM is safe in very young children, with AID systems proving superior to traditional therapy, and real-world evidence supports incorporating AID consideration into future international guidelines from the time of pediatric diagnosis.

M. Marigliano, A. Scaramuzza, C. Arnaldi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.